Glutamate is one of the major excitatory neurotransmitters in the central nervous system. Increasing glutamate leads to neurodegenerative disease. Nowadays, plant medicine plays a role in the treatment of some disorders. 
Introduction
Glutamate is released to synaptic spaces as a neuro transmitter in the central nervous system (CNS) and acts via binding to its receptor protein [3, 5] . Increas ing the glutamate concentration in the brain can lead to a number of neurodegenerative diseases such as stroke, epilepsy, depression, and Huntington's disease [18, 28] . In vitro studies have shown that high con centrations of glutamate act as a potent neurotoxin that causes the death of neurons by apoptosis [9, 10] . Different mechanisms can play role in glutamate toxicity in neuronal cells. Some of the mechanisms include activation of calciumdependent enzymes [1] , nitric oxide synthase [6] , and the production of reac tive oxygen species [39] . Recent studies have shown that antioxidant compounds, such as vitamin E [35] , curcumin, and epicatechin gallate, protect primary cul tured neurons from glutamateinduced cell death [41] . However, excessive accumulation of free radicals is responsible, at least in part, for glutamateinduced neuropathologies. Since plant medicinals contain dif ferent active ingredients, such as antioxidants, they may represent a viable approach by which glutamate toxicity can be reduced [32] . The present study was designed to evaluate the hypothesis that Ferula gummosa extract can protect neuronal cells against gluta mateinduced toxicity. F. gummosa Boiss is from the Umbelliferae (Apiaceae) family. F. gummosa is known as barijeh in Persian. This plant grows in the northern and western parts of Iran. In traditional medicine, the roots of F. gummosa was used as a tonic, emmena gogue, antidiarrhoea treatment, stomach pain medi cine, epilepsy therapy, and as a wound healing remedy [8, 25] . F. gummosa is composed of coumarin deriva tives, such as umbelliprenin and terpenoids, and ses quiterpenes such as linalool, terpinolene, and valen cene [30] . F. gummosa has different pharmacological effects including anticonvulsant [38] , antinociceptive and antiinflammatory [30] , antioxidant [7] , antimi crobial [37] , and antiproliferative effects [19, 11, 14] . The presence of phenols and flavonoids in the extract can be responsible for the observed effects [7] . In this research, the neuroprotective effect of F. gummosa was evaluated on PC12 and N2a cell lines.
Material and methods
Reagents and chemicals 3(4,5dimethylthiazol2yl)2,5diphenyl tetrazo lium (MTT), thiobarbituric acid (TBA), 2,7dichloro fluorescin diacetate (DCFHDA), propidium iodide (PI), sodium citrate, and Triton X100 were purchased from Sigma (St. Louis, MO, USA). Highglucose Dul becco's modified Eagle's medium (DMEM), peni cillinstreptomycin, and foetal bovine serum were purchased from Gibco. Trichloroacetic acid (TCA) and malondialdehyde bis(dimethyl acetal) (MDA) were obtained from Merck (Darmstadt, Germany). Rat pheochromocytoma (PC12, Pasteur Institute, C1553, Tehran, Iran) and mouse neuroblastoma (N2a, ATCC, CCL131PC12) cells were obtained from the Pasteur Institute (Tehran, Iran).
Preparation of extract Plant material and extraction
The F. gummosa roots were collected from Alibo lagh Valley (Khorasan Razavi Province, northeast Iran), and identified by Mohammadreza Joharchi, Ferdowsi University of Mashhad Herbarium (Voucher Specimen No. 4577). The hydroalcoholic extract was prepared using the Soxhlet method. The powder of F. gummosa roots was subjected to extraction with 70% ethanol in a Soxhlet apparatus for 48 h [12] , and the hydroalcoholic solvent was then evaporated by drying the extract in a water bath. The solid residue was stored at -20°C until use.
Standardizing the Ferula gummosa extract
The hydroalcoholic extract of F. gummosa root was standardized by measuring the level of total phenol using the FolinCiocalteu reagent. A sample of F. gummosa extract (20 µl of 10 mg/ml) or gal lic acid standard solutions was mixed with 100 µl FolinCiocalteu reagent and 300 µl sodium carbon ate solution (1 M), and the volume was adjusted to 2 ml using deionised water. After two hours of incu bation at room temperature, the absorbance was measured at 765 nm by spectrometer, and a stan dard curve was prepared for gallic acid. The total phenol level was expressed as milligrams of gallic acid equivalents per gram of dry F. gummosa extract.
Cell culture and treatment
The cells were maintained at 37°C in a humidi fied atmosphere that contained 5% CO 2 . The cells were cultured in DMEM supplemented with 10% foetal bovine serum, 100 units/ml penicillin, and 100 µg/ml streptomycin. For the experiments, they were seeded in 96well and 24well culture plates for MTT/ROS and MDA assays, respectively. For apopto sis assay, cells were seeded at 100,000 cells/well in a 24well plate. All treatments were carried out in triplicate. The cells were pretreated with extract alone (25 to 200 µg/ml) for 2 h, and then incubation was continued for 24 h in the presence of the extract with or without 8 mM glutamate.
Cell viability assay
The MTT assay was applied for determination of cell viability [17] . The MTT powder was dissolved in phosphatebuffered saline (5 mg/ml) and added to each well at a final concentration of 0.05%. After 3 h, the formazan precipitate was dissolved in DMSO. The absorbance at 570 and 620 nm (background) was measured using a Stat FAX 303 plate reader.
Lipid peroxidation assay
The MDA was measured as lipid peroxidation index [17] . At the end of incubation, the cells were scraped and centrifuged for 30 min. Then 400 µl of TCA (15%) and 800 µl of TBA (0.7%) were added to 500 µl of cell samples. The mixture was vortexed and heated for 40 min in a boiling water bath. Then, 200 µl of the sample was transferred to a 96well plate, and the fluorescence intensity was read with exci tation/emission of 480/530 nm. The experiment was carried out in triplicate.
Measurement of reactive oxygen species
The level of ROS was measured by DCFHDA. At the end of the incubation, the cells were treated (30 min) with DCFHDA (10 µM) at 4 o C in the dark. The fluorescence intensity was then detected with exci tation/emission of 485/530 nm. The experiment was performed in triplicate.
Propidium iodide staining
Propidium iodide (PI) staining was used for detec tion of apoptotic cells. It has previously been report ed that a subG1 peak that is reflective of DNA frag mentation can be observed following the incubation of cells in a hypotonic phosphatecitrate buffer con taining a quantitative DNAbinding dye such as PI. Apoptotic cells that have lost DNA will take up less stain and appear on the left side of the G1 peak in the histogram. Briefly, the cells were seeded in wells of a 24well plate and treated according to the men tioned protocol. Floating and adherent cells were then harvested and incubated at 4°C overnight in the dark with 750 µl of a hypotonic buffer (50 µg/ml PI in 0.1% sodium citrate with 0.1% Triton X100). Next, flow cytometry was conducted using a FACScan flow cytometer (Becton Dickinson). A total of 104 events were acquired with FACS.
Statistics
All data were expressed as mean ± SEM. Statistical analyses were performed using oneway analysis of variance (ANOVA) followed by Tamhane's T2 posthoc test. Differences were considered significant at p < 0.05.
Results

Total phenol content of Ferula gummosa extract
The solid residue of Soxhlet hydroalcoholic extract of F. gummosa was 19%. Concentration of total phe nol was 24 mg gallic acid equivalent per gram of dry F. gummosa extract.
Ferula gummosa significantly decreased the cell deaths induced by glutamate
To study the possible toxic effects of extracts PC12 and N2a cells were incubated with different concentrations of extract (6200 mg/ml), and the viability was determined 24 h after treatment. No significant toxic effect on cell viability was seen sub sequent to treatment with extract. Incubation with glutamate significantly decreased cell viability to 51 ± 0.54% of control (p < 0.001). Results showed that treatment of PC12 cells with the extract increased cell viability at concentrations of 12200 µg/ml (12 µg/ml, 68 ± 1.48%, p < 0.05, 25 µg/ml, 72 ± 2.58%, p < 0.01; 50 µg/ml, 78 ± 2.8%, p < 0.001; 100 µg/ml, 82 ± 4.38%, p < 0.001; 200 µg/ml, 87 ± 2.65%, p < 0.001), while glutamate decreased cell via bility to 50 ± 2.6%, p < 0.01 (Fig. 1A) . As shown in Fig  ure 1B , treatment of N2a cells with extract increased cell viability subsequent to glutamate insult at concentrations of 25200 µg/ml dose dependently (25 µg/ml, 65 ± 2.1%, p < 0.05; 50 µg/ml, 72 ± 1.9%, p < 0.001; 100 µg/ml, 80 ± 2.2%, p < 0.001; 200 µg/ml, 86 ± 2.5%, p < 0.001).
Ferula gummosa significantly decreased ROS content induced by glutamate
As expected, glutamate caused a significant increase in the level of ROS in PC12 cells (260 ± 7.8% of control, p < 0.001). Extract at concentrations of 25200 µg/ml was able to decrease intracellular ROS levels to 227 ± 6.1% (p < 0.05), 211 ± 7.14% (p < 0.01), 187 ± 6.2% (p < 0.001), and 172 ± 5.7% (p < 0.001) of con trol, respectively ( Fig. 2A) . Also, the extract decreased ROS levels in N2a cells at concentrations of 50 µg/ml (168 ± 4.5%, p < 0.05), 100 µg/ml (151 ± 9.1%, p < 0.01), and 200 µg/ml (133 ± 4.8%, p < 0.001) against gluta mate (210.7 ± 11%, p < 0.001) (Fig. 2B) .
Ferula gummosa significantly decreased lipid peroxidation induced by glutamate
The level of lipid peroxidation was evaluated by measuring the level of MDA, which is the end prod uct of lipid peroxidation. As shown in Figure 3 , expo sure of the cells to glutamate resulted in a signifi cant increase of MDA level in PC12 cells (269 ± 7.5%, p < 0.001) as compared to control cells cultured in the absence of glutamate (100 ± 4.5%). The content of MDA was significantly decreased in the cells pre treated with 25 µg/ml (209 ± 7.6%, p < 0.05), 50 µg/ ml (193 ± 11.6%, p < 0.01), 100 µg/ml (158 ± 9.7%, p < 0.001), and 200 µg/ml (142 ± 10.9%, p < 0.001) of extract (Fig. 3A ). The extract reduced the level of MDA at 25 µg/ml (173 ± 7%, p < 0.05), 50 µg/ml (156 ± 4.5%, p < 0.01), 100 µg/ml (143 ± 10%, p < 0.001), and 200 µg/ml (130 ± 3.7%, p < 0.001) against glutamate (214 ± 8.3%, p < 0.001) (Fig. 3B) .
Ferula gummosa significantly decreased apoptotic cell death induced by glutamate
Apoptosis in PC12 and N2a cell lines was detect ed with flow cytometry using PI staining. Cells were pretreated for 2 h with various concentrations of 
Discussion
This study showed, for the first time, that F. gummosa has significant neuroprotective effects against glutamateinduced cytotoxicity in PC12 and N2a cells in a dosedependent manner. Whereas, dopa mine and glutamate are synthesised in PC12 cell line [13] ; however, this cell line can be appropriate for some studies, such as function of neurons, neuro nal differentiation, and neurotoxicity [25] . PC12 cells are sensitive to glutamate toxicity; therefore, they can be used as a suitable model for investigating whether an extract has protective effect against glu tamateinduced cytotoxicity. Increasing of glutamate can led to neuronal death in cerebral ischaemia [23] via glutamate receptormediated [21] and oxidative stressmediated [4, 15] . Recent studies have shown that glutamate exerts its toxic effects on PC12 in a dose and timedependent manner. Its toxic concen tration varies between 0.01 and 10 mM [29, 34] , while incubation time varies from 30 min to 3122448 h. The cytotoxicity effect of glutamate at very high dos es [33] (510 mM) is independent of receptors and is mediated through the depletion of GSH and oxidative glutamate toxicity [25] . One way to reduce glutamate toxicity is to use antioxidant compounds such as medicinal plants. Recent studies have shown some herbal medicines have protective effects against glutamate such as peel and seed extract of Citrus aurantium [16] , Persea major [8] , Uncaria sinensis [20] , Scrophularia striata Boiss [36] , and Withania somnifera [22] . In this research, we used Ferula gummosa extract against glutamate toxicity in two cell lines: PC12 and N2a. The results revealed that the extract reduced ROS, lipid peroxidation, and apoptotic cells in treated cells in comparison with the glutamate group. There are different compounds in F. gummosa such as coumarin derivatives (umbelliprenin and terpenoids) and sesquiterpenes (linalool, terpinolene, and valen cene) [30] . Polyphenols are found in vegetables, fruits, grains, bark, roots, and tea [26] . These compounds are important antioxidants [40] that have a neuroprotec tion effect against glutamateinduced excitotoxicity and ischaemiainduced neurodegeneration [27, 31] . The studies have shown that linalool and eugenol, which are found in F. gummosa, have neuroprotec tive effects [2, 24] . Eugenol is an agonist on γamino butyric acid [23] (GABA) and an antagonist on NMDA (NmethylDaspartate) glutamate receptors, which play an important role in pain transmission [2] . Also, linalool inhibits glutamate release in vitro and in vivo [24] . However, the results observed in this study may be related to the active compounds of F. gummosa; more studies are required to understand the accuracy mechanism in more detail.
Disclosure
Authors report no conflict of interest.
